Physio-Control, a wholly owned subsidiary of Medtronic, has received clearance from the FDA to market the Lifepak 15 monitor/defibrillator within the US.
Subscribe to our email newsletter
Brian Webster, president of Physio-Control, said: “With the Lifepak 15 monitor/defibrillator, Physio-Control is delivering on its commitment to provide innovative, reliable and durable equipment to emergency personnel so they can focus on the most important task at hand – saving lives.
“This industry was built on the innovations delivered by Physio-Control and the Lifepak 15 monitor continues to define the new standard for emergency care products.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.